Archived Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition
Date: Apr. 30, 2021
Time: 11:00 a.m. - 12:00 p.m.
About This Lecture
Epithelial-mesenchymal transition (EMT) is a normal differentiation process during development that enables epithelial cells to partially or completely repress epithelial junctions and reprogram gene expression, resulting in more motile and often more invasive cell behavior. EMT, which is generally thought of as a reversible process, allows the cells to reach new destinations and generate new cell populations. EMT is also repurposed pathologically during fibrosis and cancer progression, and allows carcinoma cells to disseminate, while additionally enabling the cells to acquire stem cell characteristics and cancer drug resistance. Studying the activities and signaling pathways of a secreted growth factor and cytokine, named transforming growth factor-beta (TGF-beta), it was shown a long time ago that TGF-beta can induce EMT. Consistent with this notion and its known activities, increased TGF-beta signaling is now seen as a driver of fibrosis and cancer dissemination that leads to metastasis. Dr. Dernyck's research highlights the cooperation of two signaling pathways, Smad signaling and Akt-mTOR signaling, in the progression and completion of EMT, and illustrates that prolonged exposure of cancer cells stabilizes EMT, which stands in contrast to the general notion that EMT is always reversible. When compared to reversible EMT, stabilized EMT has increased stem cell properties and cancer stem cell properties that depend on mTOR signaling. The recognition of the roles of EMT in fibrosis and cancer, and the key role of TGF-beta as driver of the EMT process allow for therapeutic opportunities.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. Presented virtually via Zoom primarily for research and clinical audiences, the lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home Item
Is It What You Eat or When You Eat? Evidence for Time Restricted Eating in Humans , homeFeb. 27, 2026, 11:00 a.m. | Lisa Chow, M.D., Professor of Medicine, Pennock Family Land Grant Chair in Diabetes Research, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
A Nicotine-Focused Regulatory Strategy: The Science , homeMarch 13, 2026, 11:00 a.m. | Dorothy Hatsukami, Ph.D., Professor of Psychiatry and Behavioral Sciences and Forster Family Chair in Cancer Prevention, Masonic Cancer Center, University of Minnesota | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – Roanoke
-
Home Item
From BDNF to Rett Syndrome: Synapses, Networks, and Social Behaviors in Mecp2 Mutant Mice , homeMarch 27, 2026, 11:00 a.m. | Lucas Pozzo-Miller, Ph.D., Mall Family Endowed Professor for Genetic Autism Research, Department of Pediatrics & Human Development, College of Medicine, Michigan State University | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
The Effects of Aging and Physical Activity on Cardiovascular Structure and Function , homeApril 10, 2026, 11:00 a.m. | Ben Levine, M.D., Professor of Medicine and Cardiology, Clinical Heart and Vascular Center, Distinguished Professorship in Exercise Sciences, UT Southwestern Medical Center | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home Item
The Golden Age of Immunology Research , homeApril 16, 2026, 5:30 p.m. (Reception at 5 p.m.) | Lewis Lanier, Ph.D., J. Michael Bishop Distinguished Professor and Chair Emeritus, Department of Microbiology and Immunology, University of California, San Francisco; Elected Member, National Academy of Sciences | Maury Strauss Distinguished Public Lecture
Rik Derynck, Ph.D.
Professor, Department of Cell/Tissue Biology, and Department of Anatomy; Co-Director, UCSF Institute of Regeneration Medicine; Co-Director, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco